LAWRENCE, Mass., Jan. 19, 2016 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical technology company
focused on advancing renal care, today announced plans to release
its financial results for the fourth quarter and full year ended
December 31, 2015, on Wednesday, February 10, 2016, before the opening
of the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, February 10, 2016 to discuss its
fourth quarter and full year financial results. To listen to
the conference call, please dial 877-392-9886 (domestic) or
707-287-9329 (international). The call will also be webcast
LIVE and can be accessed via the investor relations section of the
Company's website at http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through February 17, 2016. To access the replay,
dial 855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 26460722. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is
a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
also has established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's websites at www.nxstage.com
and www.nxstagekidneycare.com.
Forward-Looking Statements
This Release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
contained in this Release that are not clearly historical in nature
are forward-looking, and the words "anticipate", "believe",
"expect", "estimate", "plan" and similar expressions are generally
intended to identify forward- looking statements. The
forward-looking statements in this Release include NxStage's plan
to release its financial results on February
10, 2016. Actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors including, but not limited to, unexpected
difficulty in closing the Company's financial books for the quarter
and other factors that are discussed in NxStage's Quarterly Report
on Form 10-Q for the quarter ended September
30, 2015 filed with the SEC. NxStage is under no obligation
to (and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
Logo - http://photos.prnewswire.com/prnh/20150624/225341
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-fourth-quarter-and-full-year-2015-financial-results-300205463.html
SOURCE NxStage Medical, Inc.